Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma

Cancer Journal from Scientific American

Volumn 4, Issue 2, 1998, Pages 125-131

  Machiavelli, Mario R ^a   Romero, Alberto O ^a   Pérez, Juan E ^a   Lacava, Juan A ^a   Domínguez, María E ^a   Rodríguez, Ricardo ^a   Barbieri, Mario R ^a   Romero Acuña, Luis A ^a   Romero Acuña, Juan M ^a   Langhi, Mario J ^a   Amato, Sonia ^a   Ortiz, Eduardo H ^a   Vallejo, Carlos T ^a   Leone, Bernardo A ^a  

^a GOCS Neuquén ^*

Author keywords

Locally advanced breast carcinoma; Neoadjuvant chemotherapy; Prognostic factors

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; SKIN MANIFESTATION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032463682     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hortobagyi GN, Buzdar AU. Locally advanced breast cancer: a review including the M.D. Anderson experience. In: Ragaz J, Ariel IM, eds. High-Risk Breast Cancer: Therapy. Berlin: Springer 1991:382-415.
2. Semiglazov VF, Topuzov EE, Bavli JL. Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Ann Oncol 1994;5: 591-595.
3. Hortobagyi GN. Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer 1994;74:416-423.
4. Trimble EL, Ungerleider RS, Abrams JA et al. Neoadjuvant therapy in cancer treatment. Cancer 1993;72:3515-3544.
5. Bonadonna G, Veronesi U, Brambilla C et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82;1539-1545.
6. American Joint Committee on Cancer. Manual for Staging of Cancer (3rd ed). Philadelphia: J.B. Lippincott, 1988:145-148.
7. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981;47:207-214.
8. Kaplan EC, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:437-481.
9. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation for each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
10. Abacus Concepts, Stat View Reference. Abacus Concepts, Inc., Berkeley, CA, 1996.
11. Simes RJ, Zelen M. Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer. J Clin Oncol 1985;3:1418-1431.
12. Bonadonna G, Valagussa P. Primary chemotherapy in operable breast cancer. Semin Oncol 1996;23:461-474.
13. McCready D, Hortobagyi GN, Kau SW et al. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 1989;124:21-25.
14. Fisher B, Brown A, Mamounas E et al. Effect of preoperative therapy for primary breast cancer (BC) on local-regional disease, disease-free survival (DFS) and survival (S): results from NSABP B-18. Proc Am Soc Clin Oncol 1997;16:449.
15. Fracchia AA, Evans JF, Eisenberg BL. Stage III carcinoma of the breast: a detailed analysis. Ann Surg 1980;192:705-710.
16. Scholl SM, Fourquet A, Asselain B, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomized trial: S6. Eur J Cancer 1994;30A:645-652.